Cargando…

Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center

BACKGROUND: Cases of novel coronavirus disease 2019 (COVID-19) were first reported in Wuhan, China, in December 2019. In this report, we describe 3 clusters of COVID-19 infections among healthcare workers (HCWs), not associated with patient exposure, and the interventions undertaken to halt ongoing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariza-Heredia, Ella J., Frenzel, Elizabeth, Cantu, Sherry, Carlson, Mary, Thomas, Georgia, Khawaja, Fareed, Raad, Issam I., Chemaly, Roy F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737142/ https://www.ncbi.nlm.nih.gov/pubmed/33183368 http://dx.doi.org/10.1017/ice.2020.1315

Ejemplares similares

Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
por: Khawaja, Fareed, et al.
Publicado: (2023)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

Outcomes of Hospital-Associated Covid-19 in Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience
por: Srinivasan, Krithika, et al.
Publicado: (2022)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
por: Daher, Marilyne, et al.
Publicado: (2022)

922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis
por: Spallone, Amy, et al.
Publicado: (2021)

Coronavirus Disease-2019 in the Immunocompromised Host
por: Bertini, Christopher D., et al.
Publicado: (2023)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

2798. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality
por: Martinez, Daniel De La Rosa, et al.
Publicado: (2019)

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
por: Khawaja, Fareed, et al.
Publicado: (2019)

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
por: Khawaja, Fareed, et al.
Publicado: (2022)

Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic
por: Spallone, Amy, et al.
Publicado: (2022)

1914. Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B.1.1.529 In a Comprehensive Cancer Center
por: Dib, Rita Wilson, et al.
Publicado: (2022)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
por: Wilson Dib, Rita, et al.
Publicado: (2023)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014
por: Kmeid, Joumana, et al.
Publicado: (2019)

1086. COVID-19 in a Comprehensive Cancer Center: 2020-2022
por: Mulanovich, Patricia, et al.
Publicado: (2022)

2681. Outcomes Related to Respiratory Viral Infections in Cancer Patients on PD-1 Inhibitors
por: Khawaja, Fareed, et al.
Publicado: (2019)

2730. Clinically significant cytomegalovirus infection in patients with lymphoma and no prior cellular therapy
por: Zubovskaia, Anna, et al.
Publicado: (2023)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

Coronavirus sampling and surveillance in bats from 1996–2019: a systematic review and meta-analysis
por: Cohen, Lily E., et al.
Publicado: (2023)

416. Culture-Documented Invasive Mold Infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, Texas Pre- and Post-Hurricane Harvey
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2018)

Surveillance of endemic human Coronaviruses in Germany, 2019/2020
por: Biere, Barbara, et al.
Publicado: (2021)

Level of Anxiety Among Healthcare Workers at a Comprehensive Cancer Center During the Coronavirus Disease 2019 Pandemic
por: Alghanmi, Hosam A, et al.
Publicado: (2021)

Multidimensional Tensor Scan for Drug Overdose Surveillance
por: Neill, Daniel B.
Publicado: (2017)

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
por: Khawaja, Fareed, et al.
Publicado: (2023)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

Comprehensive review of coronavirus disease 2019 (COVID-19)
por: Chauhan, Shaylika
Publicado: (2020)

Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019
por: Jose, Thulasee, et al.
Publicado: (2020)

The impact of coronavirus disease 2019 on surveillance colonoscopies in South Australia
por: Wassie, Molla M, et al.
Publicado: (2021)

Surveillance system for coronavirus disease 2019 epidemiological parameters in Croatia
por: Capak, Krunoslav, et al.
Publicado: (2020)

Otitis media in coronavirus disease 2019: a case series
por: Raad, N, et al.
Publicado: (2021)

Multidimensional Semantic Scan for Pre-Syndromic Disease Surveillance
por: Nobles, Mallory, et al.
Publicado: (2019)

Social Media Multidimensional Analysis for Intelligent Health Surveillance
por: Aramburu, María José, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19), Videoconferencing, and Gender
por: Wang, Sherry S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0dpbqr3f5tq7dqo67io4bli2s9